| Literature DB >> 31737405 |
Yongsheng Qu1, Liang Wang1, Wei Guo1.
Abstract
The leaves of Morus alba (LMA) are crucial traditional Chinese medicine (TCM) of clearing heat. In ancient Chinese materia medica and the current Pharmacopoeia of the People's Republic of China, LMA are recorded to be harvested after frost for medicinal purpose. However, the reason and mechanism of this traditional usage have been still unknown so far. In this work, it was confirmed firstly that the antipyretic effect of LMA after frost was better than that of before frost significantly on feverish rats. Subsequently, the chemical profiles of LMA before and after frost were characterized by fingerprint, respectively. Then, the endemic peaks after frost and positive differential peaks were screened as the research object of spectrum-effect correlation by orthogonal signal correction partial least square discrimination (OPLS). Finally, a multivariable and continuous-index spectrum-effect correlation model coupled with OPLS was established. As a result, the antipyretic components of postfrost LMA were screened and identified as citric acid derivative and tryptophan which may be the synergistic material basis. The study can provide a scientific foundation for the enhancement of effects in the postfrost LMA. Moreover, the strategy of this research could provide a valuable reference for revealing the material basis of synergetic or antagonistic effects among other complex drug systems.Entities:
Year: 2019 PMID: 31737405 PMCID: PMC6815998 DOI: 10.1155/2019/8796276
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Information of samples.
| No. of samples | No. of plants | |
|---|---|---|
| Prefrost | A1 | 1 |
| A2 | 2 | |
| A3 | 3 | |
| A4 | 4 | |
| A5 | 5 | |
| A6 | 6 | |
| A7 | 7 | |
| A8 | 8 | |
| A9 | 9 | |
| A10 | 10 | |
|
| ||
| Postfrost | B1 | 1 |
| B2 | 2 | |
| B3 | 3 | |
| B4 | 4 | |
| B5 | 5 | |
| B6 | 6 | |
| B7 | 7 | |
| B8 | 8 | |
| B9 | 9 | |
| B10 | 10 | |
Figure 1The temperature curve of prefrost and postfrost samples.
The antipyretic data of prefrost and postfrost samples (, n = 6).
| Time (h) | CG | MG | AG | Pre-AG | Post-AG |
|---|---|---|---|---|---|
| 6.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 7.5 | 0.20 ± 0.21 | 0.28 ± 0.20 | −0.02 ± 0.33 | 0.20 ± 0.15 | 0.01 ± 0.27 |
| 8.5 | 0.30 ± 0.20 | 0.41 ± 0.29 | 0.33 ± 0.27 | 0.35 ± 0.11 | 0.15 ± 0.18 |
| 9.5 | 0.18 ± 0.49 | 0.33 ± 0.37 | 0.10 ± 0.33 | 0.25 ± 0.07 | 0.09 ± 0.19 |
| 10.5 | 0.08 ± 0.37 | 0.24 ± 0.40 | −0.03 ± 0.36 | 0.18 ± 0.13 | −0.11 ± 0.21 |
| 11.5 | −0.10 ± 0.29 | 0.12 ± 0.34 | 0.12 ± 0.41 | 0.05 ± 0.20 | −0.24 ± 0.23 |
| 12.5 | −0.20 ± 0.50 | 0.01 ± 0.59 | −0.08 ± 0.75 | −0.16 ± 0.16 | −0.46 ± 0.26 |
| 13.5 | −0.17 ± 0.29 | −0.15 ± 0.34 | −0.32 ± 0.4 | −0.36 ± 0.16 | −0.54 ± 0.24 |
| 14.5 | 0.00 ± 0.35 | −0.46 ± 0.38 | −0.53 ± 0.36 | −0.50 ± 0.20 | −0.68 ± 0.18 |
| 15.5 | −0.22 ± 0.31 | −0.60 ± 0.22 | −0.63 ± 0.35 | −0.67 ± 0.17 | −0.81 ± 0.14 |
| 16.5 | −0.08 ± 0.34 | −0.71 ± 0.17 | −0.72 ± 0.28 | −0.81 ± 0.13 | −0.97 ± 0.22 |
| 17.5 | −0.28 ± 0.32 | −0.87 ± 0.25 | −0.95 ± 0.34 | −0.90 ± 0.24 | −0.88 ± 0.19 |
| 18.5 | −0.13 ± 0.31 | −0.86 ± 0.23 | −0.9 ± 0.33 | −0.92 ± 0.21 | −0.89 ± 0.10 |
p < 0.05 and p < 0.01, compared to MG, respectively.
Figure 2The fingerprints of prefrost and postfrost samples. (a) Prefrost. (b) Postfrost.
Figure 3The hierarchical clustering plot of prefrost and postfrost samples.
Compounds identified from LMA fingerprint.
| No. | RT (min) | +TOF-MS (ion) ( | Diff (ppm) | −TOF-MS (ion) ( | Diff (ppm) | +MS | −MS | M.W. | Formula | Identification | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6.448 | 429.0251 (M + Na)+ | −6.64 | 405.0249 (M−H)− | 0.75 | 407.1 | 405.0 ⟶ 190.9 ⟶ 111.1 | 406 | C21H10O9 | Citric acid derivativeb | [ |
| 2 | 9.425 | 330.0609 (M + H)+ | −0.22 | 328.0446 (M−H)− | 5.09 | 330.1 ⟶ 136.1 | 328 ⟶ 133.9 | 329 | C16H11NO7 | Alkaloid | |
| 3 | 12.159 | 346.0545 (M + H)+ | 3.60 | 344.0407 (M−H)− | 1.42 | 346.1 ⟶ 152.1 ⟶ 109.1 | 343.9 ⟶ 149.9 | 345 | C16H11NO8 | Alkaloid | |
| 4 | 20.457 | 339.0680 (M + Na)+ | 2.07 | 315.0706 (M−H)− | 4.92 | 339.2⟶185.0 | 315.0 ⟶ 152.9 ⟶ 109.0 | 316 | C13H16O9 | Dihydroxybenzoic acid hexosideb | [ |
| 6 | 26.642 | 538.1246 (M + H)+ | 5.05 | 536.1115 (M−H)− | 2.55 | 538.3 ⟶ 334.1 ⟶ 231.1 ⟶ 185.0 | 536.1 ⟶ 518.1 ⟶ 272.3 | 537 | C34H17NO6 | Alkaloid | |
| 8 | 28.44 | 339.0689 (M + Na)+ | −0.78 | 315.0721 (M−H)− | 0.18 | 339.1 ⟶ 254.7 ⟶ 109.2 | 315.0 ⟶ 152.0 ⟶ 109.0 | 316 | C13H16O9 | Dihydroxybenzoic acid hexosideb | [ |
| 11 | 36.743 | 539.1375 (M + Na)+ | −0.72 | 515.1404 (M−H)− | 0.44 | 515.2 ⟶ 178.8 (352.9) ⟶ 135.0 | 516 | C22H28O14 | Chlorogenic glycosideb | [ | |
| 12 | 40.471 | 355.1039 (M + H)+ | −4.35 | 353.0871 (M−H)− | 1.99 | 355.1 ⟶ 163.1 ⟶ 145.1 ⟶ 117.3 | 353.0 ⟶ 190.9 ⟶ 172.9 | 354 | C16H18O9 | Neochlorogenic acidab | [ |
| 14 | 45.428 | 205.0966 (M + H)+ | 2.71 | 203.0813 (M−H)− | 6.38 | 205.1 ⟶ 188.1 | 203.0 ⟶ 159.0 ⟶ 129.9 | 204 | C11H12N2O2 | Tryptophanab | [ |
| 16 | 55.956 | 355.1005 (M + H)+ | 5.25 | 353.0883 (M−H)− | −1.40 | 355.2 ⟶ 163.1 ⟶ 145.1 | 353.0 ⟶ 190.9 ⟶ 85.2 | 354 | C16H18O9 | Chlorogenic acidb | [ |
| 18 | 61.352 | 355.1031 (M + H)+ | −2.09 | 353.0887 (M−H)− | −2.53 | 355.1 ⟶ 163.1 ⟶ 145.1 | 353.0 ⟶ 172.9 (191.0) ⟶ 93.1 | 354 | C16H18O9 | 4-caffeolyquinic acidb | [ |
| 19 | 63.725 | 573.2507 (M + Na)+ | 1.93 | 595.2632 (M + HCOO)− | −4.46 | 573.4 ⟶ 393.3 ⟶ 362.7 | 595.3⟶549.3⟶478.9 ⟶ 253.0 | 550 | C25H42O13 | Tricalysionoside Ab | [ |
| 20 | 66.36 | 409.1824 (M + Na)+ | 2.30 | 431.1907 (M + HCOO)− | 4.07 | 409.3 ⟶ 391.2 ⟶ 299.0 | 431.1⟶178.9 ⟶ 89.2 | 386 | C19H30O8 | Roseoside II or isomerb | [ |
| 22 | 71.239 | 409.1831 (M + Na)+ | 0.49 | 431.1950 (M + HCOO)− | −7.07 | 409.3 ⟶ 391.1 ⟶ 334.8 | 431.1 ⟶ 385.1 ⟶ 153.0 ⟶ 138.0 | 386 | C19H30O8 | Roseoside II or isomerb | [ |
| 23 | 74.107 | 589.1529 (M + Na)+ | −0.22 | 611.1642 (M + HCOO)− | −4.31 | 589.3 ⟶ 427.2 ⟶ 131.2 | 611.2 ⟶ 565.1⟶ 403.0 ⟶ 240.8 | 566 | C26H30O14 | Mulberroside Fb | [ |
| 24 | 76.398 | 411.1980 (M + Na)+ | 2.42 | 433.2091 (M + HCOO)− | −3.04 | 411.3 ⟶ 393.3 ⟶ 346.3 | 433.2 ⟶ 387.1 ⟶ 161.0 | 388 | C19H32O8 | Roseoside II or isomerb | [ |
| 25 | 77.723 | 633.1408 (M + Na)+ | 2.96 | 609.1483 (M-H)− | −3.59 | 633.3 | 609.2 ⟶ 447.0 ⟶ 285.0 | 610 | C27H30O16 | Kaempferol-hexoside-hexosideb | [ |
| 26 | 85.743 | 465.1052(M + H)+ | −5.27 | 463.0866 (M-H)− | 3.45 | 465.1 | 463.1 ⟶ 300.9 ⟶ 272.9 | 464 | C21H20O12 | Quercetin hexosideb | [ |
| 28 | 91.351 | 611.1641 (M + H)+ | −5.64 | 609.1480 (M-H)− | −3.10 | 609.1 ⟶ 299.9 ⟶ 270.9 ⟶ 242.7 | 610 | C27H30O16 | Rutin isomerb | [ | |
| 30 | 96.671 | 611.1615 (M + H)+ | −1.37 | 609.1435 (M-H)− | 4.28 | 633.3 (611.3) ⟶ 331.2 ⟶ 185.2 | 609.2 ⟶ 299.9 ⟶ 178.9 ⟶ 150.9 | 610 | C27H30O16 | Rutinab | [ |
| 31 | 99.07 | 465.106 (M + H)+ | −7.00 | 463.0891 (M-H)− | −1.94 | 465.1 ⟶ 303.1 ⟶ 229.1 ⟶ 201.0 | 463.1 ⟶ 300.9 ⟶ 150.9 ⟶ 107.1 | 464 | C21H20O12 | Isoquercitrinab | [ |
| 32 | 104.09 | 473.1995 (M + Na)+ | −0.37 | 449.2031 (M-H)− | −0.59 | 473.3 ⟶ 311.2 ⟶ 249.2 | 449.2 ⟶ 269.0 ⟶ 207.0 ⟶ 162.9 | 450 | C20H34O11 | Unknown | |
| 33 | 114.084 | 449.1063 (M + H)+ | 3.43 | 447.0899 (M-H)− | 7.50 | 449.1 ⟶ 287.1 ⟶ 258.1 ⟶ 229.3 | 447.1 ⟶ 284.0 ⟶ 254.9 ⟶ 188.9 | 448 | C21H20O11 | Astragalinab | [ |
aThe compound was identified by comparison with standard. bThe compound was identified by comparison with references.
Figure 4The S-plot of peaks.
Figure 5The loading scatter plot.
Figure 6The plot of VIP.
Figure 7The hierarchical clustering plot of prefrost and postfrost samples.